Latest News and Press Releases

Dublin, June 10, 2025 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Market - A Global and Regional Analysis: Focus on Drug Class, Country, and Region - Analysis and Forecast, 2025-2035" report has...

Dublin, March 05, 2025 (GLOBE NEWSWIRE) -- The "Parkinson's Disease Seven-Market Drug Forecast and Market Analysis" report has been added to ResearchAndMarkets.com's offering.The report estimates...

Dublin, Jan. 10, 2025 (GLOBE NEWSWIRE) -- The "Parkinson's Disease: Epidemiology Forecast to 2033" report has been added to ResearchAndMarkets.com's offering. In 2023, there were 2,636,930...

Dublin, Sept. 03, 2024 (GLOBE NEWSWIRE) -- The "Tardive Dyskinesia (TD) Market Assessment: Epidemiology, Treatment Landscape, Unmet Needs, Emerging Therapies, and Value & Access" report has been...

Dublin, April 05, 2024 (GLOBE NEWSWIRE) -- The "Tavapadon Market Size, Forecast, and Emerging Insight - 2032" report has been added to ResearchAndMarkets.com's offering.This report provides...

Dublin, Feb. 27, 2024 (GLOBE NEWSWIRE) -- The "Dyskinesia - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering. The global healthcare industry witnesses a pivotal...

Dublin, Jan. 31, 2024 (GLOBE NEWSWIRE) -- The "Global Tardive Dyskinesia Therapeutics Market Analysis & Forecast to 2024-2034" report has been added to ResearchAndMarkets.com's offering. The...

Tel Aviv, Israel / Vancouver, Canada, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (NASDAQ: CMND) (CSE: CMND), (FSE: CWY) (“Clearmind” or “the company"), a biotech company focused on...

Pune, India, May 23, 2023 (GLOBE NEWSWIRE) -- According to Fortune Business Insights, the tardive dyskinesia therapeutics market size was valued at USD 2.33 billion in 2022 and is projected to grow...

Dublin, Dec. 29, 2022 (GLOBE NEWSWIRE) -- The "Autism Spectrum Disorder Treatment Market by Treatment, Application, Distribution Channel, and by Region - Global Forecast to 2022-2033" report has...